Opportunistic Dermatophyte Infections in Immunocompromised Patients With Rheumatoid Arthritis: A Review Article
DOI:
https://doi.org/10.21070/ijhsm.v2i1.186Keywords:
Dermatophyte, Fungi, Immunocompromised, Rheumatoid Arthritis, OpportunisticAbstract
Background: Opportunistic dermatophyte infections pose an increasing issue in immunocompromised individuals, especially those with rheumatoid arthritis (RA). Rheumatoid arthritis patients frequently get immunosuppressive treatment, such as corticosteroids and biologics, rendering them susceptible to fungal infections. Dermatophytes, a category of keratinophilic fungus, can induce severe and unusual infections in these patients, frequently resulting in chronic, treatment-resistant diseases. This review examines the epidemiology, risk factors, clinical symptoms, and diagnostic difficulties associated with opportunistic dermatophyte infections in individuals with rheumatoid arthritis. Additionally, it emphasizes contemporary therapeutic methods and preventive measures to reduce the risk of infection in this at-risk population. Timely diagnosis and customized antifungal therapy are essential for enhancing patient outcomes. Objectives: This study seeks to examine opportunistic dermatophyte infections in immunocompromised individuals with rheumatoid arthritis (RA), especially those receiving immunosuppressive treatment. Conclusion: The interaction between compromised immune responses and heightened vulnerability to fungal infections requires proactive prevention and early intervention techniques. By maintaining good hygiene, wearing suitable footwear, employing antifungal treatments, and obtaining prompt medical consultation, patients can significantly reduce the dangers associated with dermatophyte infections.
Highlights:
-
High Risk in RA Patients, Immunosuppressive drugs increase susceptibility to dermatophyte infections.
-
Difficult to Diagnose and Treat, Infections can become chronic and drug-resistant, requiring timely and tailored antifungal therapy.
-
Prevention Is Essential, Good hygiene, proper footwear, and early medical attention help reduce infection risk.
Keyword: Dermatophyte, Fungi, Immunocompromised, Rheumatoid Arthritis, Opportunistic
References
[1] Gupta, Chhavi, et al., "Review on host-pathogen interaction in dermatophyte infections," Journal of Medical Mycology, vol. 33.1, pp. 101331, 2023.
[2] Wang, Ruojun, et al., "Invasive dermatophyte infection: a systematic review," Mycoses, vol. 64.4, pp. 340-348, 2021.
[3] Rouzaud, Claire, et al., "Severe dermatophytosis and acquired or innate immunodeficiency: a review," Journal of Fungi, vol. 2.1, pp. 4, 2015.
[4] Toussaint, Frédéric; Sticherling, Michael, "Multiple dermal abscesses by Trichophyton rubrum in an immunocompromised patient," Frontiers in Medicine, vol. 6, pp. 97, 2019.
[5] Dubljanin, Eleonora, et al., "Host-pathogen interaction and resistance mechanisms in dermatophytes," Pathogens, vol. 13.8, pp. 657, 2024.
[6] Martinez-Rossi, Nilce M., et al., "Dermatophyte resistance to antifungal drugs: mechanisms and prospectus," Frontiers in Microbiology, vol. 9, pp. 1108, 2018.
[7] Celestrino, Giovanna Azevedo, et al., "Host immune responses in dermatophytes infection," Mycoses, vol. 64.5, pp. 477-483, 2021.
[8] Mohd Sazlly Lim, Sazlyna; Sinnollareddy, Mahipal; Sime, Fekade Bruck, "Challenges in antifungal therapy in diabetes mellitus," Journal of Clinical Medicine, vol. 9.9, pp. 2878, 2020.
[9] Zarei, Fereshteh, et al., "Molecular characterization of fungi causing colonization and infection in organ transplant recipients: a one-year prospective study," Current Medical Mycology, vol. 6.1, pp. 30, 2020.
[10] Xiao, Jin, et al., "Oral health and Candida carriage in socioeconomically disadvantaged US pregnant women," BMC Pregnancy and Childbirth, vol. 19, pp. 1-13, 2019.
[11] Ferreira, Gustavo de Sousa Arantes, et al., "Colonic infection by Histoplasma capsulatum in a liver transplant patient: a case report," Transplantation Proceedings, Elsevier, pp. 1413-1416, 2020.
[12] Pang, Wenwen, et al., "Prevalence of opportunistic infections and causes of death among hospitalized HIV-infected patients in Sichuan, China," The Tohoku Journal of Experimental Medicine, vol. 244.3, pp. 231-242, 2018.
[13] John, Ann M.; Schwartz, Robert A.; Janniger, Camila K., "The kerion: an angry tinea capitis," International Journal of Dermatology, vol. 57.1, pp. 3-9, 2018.
[14] Das, Anupam, et al., "Impact of chronic and recurrent dermatophytosis on quality of life and psychologic morbidity—a cross-sectional study," Journal of Cosmetic Dermatology, vol. 21.8, pp. 3586-3592, 2022.
[15] Bongomin, Felix, et al., "Estimation of the burden of tinea capitis among children in Africa," Mycoses, vol. 64.4, pp. 349-363, 2021.
[16] Marconi, Vincent C., et al., "Disseminated dermatophytosis in a patient with hereditary hemochromatosis and hepatic cirrhosis: case report and review of the literature," Medical Mycology, vol. 48.3, pp. 518-527, 2010.
[17] Achterman, Rebecca Rashid; White, Theodore C., "Dermatophytes," Current Biology, vol. 23.13, pp. R551-R552, 2013.
[18] White, Theodore C., et al., "Fungi on the skin: dermatophytes and Malassezia," Cold Spring Harbor Perspectives in Medicine, vol. 4.8, pp. a019802, 2014.
[19] Achterman, Rebecca R., et al., "Sequenced dermatophyte strains: growth rate, conidiation, drug susceptibilities, and virulence in an invertebrate model," Fungal Genetics and Biology, vol. 48.3, pp. 335-341, 2011.
[20] Baert, F., et al., "Updating the taxonomy of dermatophytes of the BCCM/IHEM collection according to the new standard: a phylogenetic approach," Mycopathologia, vol. 185.1, pp. 161-168, 2020.
[21] Yamada, Shigeo; Anzawa, Kazushi; Mochizuki, Takashi, "Molecular epidemiology of Microsporum canis isolated from Japanese cats and dogs, and from pet owners by multilocus microsatellite typing fragment analysis," Jpn J Infect Dis, vol. 75.2, pp. 105-113, 2022.
[22] Moskaluk, Alex, et al., "Genetic characterization of Microsporum canis clinical isolates in the United States," Journal of Fungi, vol. 8.7, pp. 676, 2022.
[23] Abd-Elmegeed, Al-Shimaa Saber, et al., "Dermatophytes and ringworm infection," 2024.
[24] Ridzuan, P. M., et al., "Mini review on dermatomycosis," Journal of Science and Mathematics Letters, vol. 8.1, pp. 6-15, 2020.
[25] Colosi, Ioana Alina, et al., "Dermatophytes and dermatophytosis in Cluj-Napoca, Romania—A 4-year cross-sectional study," Journal of Fungi, vol. 6.3, pp. 154, 2020.
[26] Numan, Rand Salwan, et al., "Review of the clinical types of dermatophytes," Journal for Research in Applied Sciences and Biotechnology, 2024, pp. 104-112.
[27] Leung, Alexander K.C., et al., "Tinea corporis: an updated review," Drugs in Context, vol. 9, 2020.
[28] Arora, Tanu, et al., "Mycological pattern of dermatophytes and non-dermatophytes in a tertiary care hospital," Int J Health Sci Res, vol. 10.4, pp. 37-41, 2020.
[29] Siegfried, Elaine C.; Hebert, Adelaide A., "Diagnosis of atopic dermatitis: mimics, overlaps, and complications," Journal of Clinical Medicine, vol. 4.5, pp. 884-917, 2015.
[30] Pakroo, Shadi; Tarrah, Armin; Omran, Ayatollah Nasrollahi, "Prevalence of dermatophytosis and assessment of antifungal susceptibility in patients referred to a mycology clinic in Tehran," Romanian Archives of Microbiology and Immunology, vol. 78.2, pp. 91-97, 2019.
[31] Alam, Shamim; Alam, Shakir, "Tinea: a concerned spot—an institutional retrospective study," Int J Hom Sci, vol. 4.2, pp. 187-193, 2020.
[32] Attal, Ruchita O.; Deotale, Vijayshri; Yadav, Akshay, "Tinea capitis among primary school children: a clinicomycological study in a rural hospital in Central India," Int J Curr Res Rev, vol. 9.23, pp. 25, 2017.
[33] Aragón-Sánchez, Javier, et al., "Onychomycosis and tinea pedis in the feet of patients with diabetes," The International Journal of Lower Extremity Wounds, vol. 22.2, pp. 321-327, 2023.
[34] Raiesi, Omid, et al., "Fungal infection in foot diabetic patients," Journal of Basic Research in Medical Sciences, vol. 5.4, pp. 47-51, 2018.
[35] Melikoğlu, Mehmet; Özdemir, Şevki; Uslu, Hakan, "The investigation of dermatophyte agents in patients with dermatophytosis diagnosis," Medicine Science, vol. 12.1, 2023.
[36] Gupta, A. K., et al., "Onychomycosis: a review," Journal of the European Academy of Dermatology and Venereology, vol. 34.9, pp. 1972-1990, 2020.
[37] Vestergaard‐Jensen, Sif, et al., "Systematic review of the prevalence of onychomycosis in children," Pediatric Dermatology, vol. 39.6, pp. 855-865, 2022.
[38] Zanardelli, Matteo, et al., Tinea Versicolor (Pityriasis Versicolor), in European Handbook of Dermatological Treatments, Cham: Springer International Publishing, pp. 1001-1008, 2023.
[39] Łabędź, Nina, et al., "Pityriasis versicolor—a narrative review on the diagnosis and management," Life, vol. 13.10, pp. 2097, 2023.
[40] Gadadavar, Santhosh, et al., "Clinico-mycological study of dermatophytosis at a tertiary care hospital in Belagavi, Karnataka, India," Int J Curr Microbiol Appl Sci, vol. 7, pp. 1872-80, 2018.
[41] Al-Khikani, Falah Hasan Obayes, "Major factors associated with worldwide dermatophytosis predominance," MGM Journal of Medical Sciences, vol. 7.4, pp. 232-233, 2020.
[42] Al-Janabi, A. A., "Dermatophytosis: Causes, clinical features, signs and treatment," J Symptoms Signs, vol. 3.3, pp. 200-3, 2014.
[43] Ameen, Mahreen, "Epidemiology of superficial fungal infections," Clinics in Dermatology, vol. 28.2, pp. 197-201, 2010.
[44] Singh, Ashutosh, et al., "High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene," Mycoses, vol. 61.7, pp. 477-484, 2018.
[45] Faway, Emilie, et al., Experimental Models of Dermatophytosis, in Dermatophytes and Dermatophytoses, Cham: Springer International Publishing, pp. 135-160, 2021.
[46] Deng, Ruixin; Wang, Xiaowen; Li, Ruoyu, "Dermatophyte infection: from fungal pathogenicity to host immune responses," Frontiers in Immunology, vol. 14, pp. 1285887, 2023.
[47] Uttamchandani, Piyu Amit; Patil, Aditya Dilipkumar, "Homoeopathy an alternative therapy for dermatophyte infections," Int J Health Sci Res, vol. 9.1, pp. 316-20, 2019.
[48] Nawfal, Basim Namah; Zghair, Fadhil Sami, "Study of immune response of immune mediator interleukin (17 and 23) against dermatophytes infection," Journal of Algebraic Statistics, vol. 13.2, pp. 2358-2365, 2022.
[49] Moriello, Karen A., et al., "Diagnosis and treatment of dermatophytosis in dogs and cats. Clinical Consensus Guidelines of the World Association for Veterinary Dermatology," Veterinary Dermatology, vol. 28.3, pp. 266-e68, 2017.
[50] Mourad, Basma, et al., "Evaluation of the efficacy of fluorescent staining and Chicago sky blue staining as methods for diagnosis of dermatophytosis in hair and nails," Clinical, Cosmetic and Investigational Dermatology, pp. 751-758, 2019.
[51] Klatte, J. L.; van der Beek, Nick; Kemperman, P. M. J. H., "100 years of Wood's lamp revised," Journal of the European Academy of Dermatology and Venereology, vol. 29.5, pp. 842-847, 2015.
[52] Begum, Jubeda, et al., "Recent advances in the diagnosis of dermatophytosis," Journal of Basic Microbiology, vol. 60.4, pp. 293-303, 2020.
[53] Li, Xiao-Fang, et al., "A new medium for diagnosis of dermatophyte infection," European Journal of Dermatology, vol. 19.1, pp. 34-37, 2009.
[54] Salkin, Ira F.; Padhye, Arvind A.; Kemna, M. E., "A new medium for the presumptive identification of dermatophytes," Journal of Clinical Microbiology, vol. 35.10, pp. 2660-2662, 1997.
[55] Poluri, Lakshmi Vasantha; Indugula, Jyothi P.; Kondapaneni, Sai L., "Clinicomycological study of dermatophytosis in South India," Journal of Laboratory Physicians, vol. 7.02, pp. 084-089, 2015.
[56] Dong, Charli, et al., "Evaluation of dermoscopy in the diagnosis of naturally occurring dermatophytosis in cats," Veterinary Dermatology, vol. 27.4, pp. 275-e65, 2016.
[57] Elwart, Olivia E., et al., "Effect of light exposure on growth rate of veterinary clinical dermatophyte isolates," Veterinary Dermatology, vol. 32.3, pp. 234-e61, 2021.
[58] Mayser, Peter; Budihardja, Debby, "A simple and rapid method to differentiate Arthroderma benhamiae from Microsporum canis," JDDG: Journal der Deutschen Dermatologischen Gesellschaft, vol. 11.4, pp. 322-327, 2013.
[59] Jacobson, Linda S.; McIntyre, Lauren; Mykusz, Jenny, "Comparison of real-time PCR with fungal culture for the diagnosis of Microsporum canis dermatophytosis in shelter cats: a field study," Journal of Feline Medicine and Surgery, vol. 20.2, pp. 103-107, 2018.
[60] Wickes, Brian L.; Wiederhold, Nathan P., "Molecular diagnostics in medical mycology," Nature Communications, vol. 9.1, pp. 5135, 2018.
[61] Bergman, A., et al., "Fast and specific dermatophyte detection by automated DNA extraction and real-time PCR," Clinical Microbiology and Infection, vol. 19.4, pp. E205-E211, 2013.
[62] Spiliopoulou, Anastasia, et al., "Evaluation of a commercial PCR test for the diagnosis of dermatophyte nail infections," Journal of Medical Microbiology, vol. 64.1, pp. 25-31, 2015.
[63] Bergmans, A. M. C., et al., "Evaluation of a single‐tube real‐time PCR for detection and identification of 11 dermatophyte species in clinical material," Clinical Microbiology and Infection, vol. 16.6, pp. 704-710, 2010.
[64] Aydin, Suleyman, "A short history, principles, and types of ELISA, and our laboratory experience with peptide/protein analyses using ELISA," Peptides, vol. 72, pp. 4-15, 2015.
[65] Santana, Aline Elisa, et al., "Development of enzyme immunoassays (ELISA and Western blot) for the serological diagnosis of dermatophytosis in symptomatic and asymptomatic cats," Medical Mycology, vol. 56.1, pp. 95-102, 2018.
[66] José, Ricardo J.; Brown, Jeremy S., "Opportunistic bacterial, viral and fungal infections of the lung," Medicine, vol. 44.6, pp. 378-383, 2016.
[67] Neville, B. Anne; D’Enfert, Christophe; Bougnoux, Marie-Elisabeth, "Candida albicans commensalism in the gastrointestinal tract," FEMS Yeast Research, vol. 15.7, pp. fov081, 2015.
[68] Bertolini, Martinna; Dongari-Bagtzoglou, Anna, The Relationship of Candida albicans with the Oral Bacterial Microbiome in Health and Disease, in Oral Mucosal Immunity and Microbiome, Springer, pp. 69-78, 2019.
[69] Gow, Neil A. R.; Hube, Bernhard, "Importance of the Candida albicans cell wall during commensalism and infection," Current Opinion in Microbiology, vol. 15.4, pp. 406-412, 2012.
[70] Bullock, Jacqueline, et al., "Rheumatoid arthritis: a brief overview of the treatment," Medical Principles and Practice, vol. 27.6, pp. 501-507, 2019.
[71] Smolen, J. S., et al., "Rheumatoid arthritis," Nature Reviews Disease Primers, vol. 4, pp. 18001, 2018.
[72] Fraenkel, Liana, et al., "2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis," Arthritis & Rheumatology, vol. 73.7, pp. 1108-1123, 2021.
[73] Capellino, Silvia, et al., "Catecholamine-producing cells in the synovial tissue during arthritis: modulation of sympathetic neurotransmitters as new therapeutic target," Annals of the Rheumatic Diseases, vol. 69.10, pp. 1853-1860, 2010.
[74] Martins, Maíra Pompeu, et al., "Comprehensive analysis of the dermatophyte Trichophyton rubrum transcriptional profile reveals dynamic metabolic modulation," Biochemical Journal, vol. 477.5, pp. 873-885, 2020.
[75] Li, Yinyin, et al., "Deficient activity of the nuclease MRE11A induces T cell aging and promotes arthritogenic effector functions in patients with rheumatoid arthritis," Immunity, vol. 45.4, pp. 903-915, 2016.
[76] Macgregor, Alexander J., et al., "Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins," Arthritis & Rheumatism, vol. 43.1, pp. 30-37, 2000.
[77] Okada, Yukinori, et al., "Genetics of rheumatoid arthritis contributes to biology and drug discovery," Nature, vol. 506.7488, pp. 376-381, 2014.
[78] GTEx Consortium, et al., "The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans," Science, vol. 348.6235, pp. 648-660, 2015.
[79] Chen, Yu-Chia, et al., "Effects of human leukocyte antigen DRB1 genetic polymorphism on anti-cyclic citrullinated peptide (ANTI-CCP) and rheumatoid factor (RF) expression in rheumatoid arthritis (RA) patients," International Journal of Molecular Sciences, vol. 24.15, pp. 12036, 2023.
[80] Puszczewicz, Mariusz; Iwaszkiewicz, Cezary, "Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis," Archives of Medical Science, vol. 7.2, pp. 189-194, 2011.
[81] Banal, Frédéric, et al., "Sensitivity and specificity of the American College of Rheumatology 1987 criteria for the diagnosis of rheumatoid arthritis according to disease duration," Annals of the Rheumatic Diseases, vol. 68.7, pp. 1184-1191, 2009.
[82] Luime, J. J., et al., "Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis?," Annals of the Rheumatic Diseases, vol. 69.2, pp. 337-344, 2010.
[83] Zeng, Tingting; Tan, Liming, "14-3-3η protein: a promising biomarker for rheumatoid arthritis," Biomarkers in Medicine, vol. 12.8, pp. 917-925, 2018.
[84] Mohamed, Samar R., et al., "Diagnostic value and clinical significance of anti-carbamylated protein (anti-CarP) antibodies in Egyptian patients with rheumatoid arthritis," The Egyptian Rheumatologist, vol. 42.1, pp. 1-4, 2020.
[85] Spierings, Julia; van Eden, Willem, "Heat shock proteins and their immunomodulatory role in inflammatory arthritis," Rheumatology, vol. 56.2, pp. 198-208, 2017.
[86] Mun, Sora, et al., "Serum biomarker panel for the diagnosis of rheumatoid arthritis," Arthritis Research & Therapy, vol. 23, pp. 1-10, 2021.
[87] Väänänen, Tuija, et al., "Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab," PLoS One, vol. 12.8, pp. e0183294, 2017.
[88] Albrecht, Katinka; Zink, Angela, "Poor prognostic factors guiding treatment decisions in rheumatoid arthritis patients," Arthritis Research & Therapy, vol. 19, pp. 1-8, 2017.
[89] Rotta, Inajara, et al., "Efficacy of topical antifungals in the treatment of dermatophytosis," JAMA Dermatology, vol. 149.3, pp. 341-349, 2013.
[90] Sahoo, Alok Kumar; Mahajan, Rahul, "Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review," Indian Dermatology Online Journal, vol. 7.2, pp. 77-86, 2016.
[91] Gupta, Aditya K.; Ryder, Jennifer E., "The use of oral antifungal agents to treat onychomycosis," Dermatologic Clinics, vol. 21.3, pp. 469-479, 2003.
[92] Trent, J. T.; Federman, D.; Kirsner, R. S., "Common viral and fungal skin infections," Ostomy/Wound Management, vol. 47.6, pp. 28-34, 2001.
[93] Seebacher, Frank; White, Craig R.; Franklin, Craig E., "Physiological plasticity increases resilience of ectothermic animals to climate change," Nature Climate Change, vol. 5.1, pp. 61-66, 2015.
[94] Sigurgeirsson, Bardur, et al., "Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison," Journal of Dermatological Treatment, vol. 17.1, pp. 38-44, 2006.
[95] Aletaha, Daniel, et al., "2010 rheumatoid arthritis classification criteria," Arthritis & Rheumatism, vol. 62.9, pp. 2569-2581, 2010.
[96] Klareskog, Lars; Gregersen, Peter K.; Huizinga, Tom W. J., "Prevention of autoimmune rheumatic disease," Annals of the Rheumatic Diseases, vol. 69.12, pp. 2062-2066, 2010.
[97] Larrieu, Thomas; Layé, Sophie, "Food for mood: relevance of nutritional omega-3 fatty acids for depression and anxiety," Frontiers in Physiology, vol. 9, pp. 1047, 2018.
[98] Morini, Virginia, et al., "Who can help me? Reconstructing users' psychological journeys in depression-related social media interactions," arXiv preprint, arXiv:2311.17684, 2023.
[99] Studenic, Paul, et al., "Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis," Annals of the Rheumatic Diseases, vol. 79.4, pp. 445-452, 2020.
[100] Moura, Mariana Del Grossi, et al., "Use of steroid and nonsteroidal anti-inflammatories in the treatment of rheumatoid arthritis," Medicine, vol. 97.41, pp. e12658, 2018.
[101] Hochberg, Marc C., "New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis," Seminars in Arthritis and Rheumatism, pp. 4-14, 2002.
[102] McWilliams, D. F., et al., "The efficacy of systemic glucocorticosteroids for pain in rheumatoid arthritis," Rheumatology, vol. 61.1, pp. 76-89, 2022.
[103] Monti, Sara, et al., "Factors influencing the choice of first- and second-line biologic therapy," Clinical Rheumatology, vol. 36, pp. 753-761, 2017.
[104] Bicer, A., et al., "Prevalence of dermatophytosis in patients with rheumatoid arthritis," Rheumatology International, vol. 23, pp. 37-40, 2003.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dhuha A. Athouf
This work is licensed under a Creative Commons Attribution 4.0 International License.
